Advertisement
Advertisement
AUPH
Aurinia Pharmaceuticals Inc
18.04
USDSponsored
-0.58
-3.11%
Jun 25, 12:39 UTC -4
Open
AUPH Earnings Reports
Positive Surprise Ratio
AUPH beat 27 of 42 last estimates.
64%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$81.29M
/$0.24
Implied change from Q1 26 (Revenue/ EPS)
+4.61%
/-4.00%
Implied change from Q2 25 (Revenue/ EPS)
+16.12%
/+50.00%
Aurinia Pharmaceuticals Inc earnings per share and revenue
On May 07, 2026, AUPH reported earnings of 0.25 USD per share (EPS) for Q1 26, beating the estimate of 0.20 USD, resulting in a 23.76% surprise. Revenue reached 77.70 million, compared to an expected 78.94 million, with a -1.56% difference. The market reacted with a -6.80% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.24 USD, with revenue projected to reach 81.29 million USD, implying an decrease of -4.00% EPS, and increase of 4.61% in Revenue from the last quarter.
FAQ
What were Aurinia Pharmaceuticals Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Aurinia Pharmaceuticals Inc reported EPS of $0.25, beating estimates by 23.76%, and revenue of $77.70M, -1.56% below expectations.
How did the market react to Aurinia Pharmaceuticals Inc's Q1 2026 earnings?
The stock price moved down -6.8%, changed from $16.25 before the earnings release to $15.14 the day after.
When is Aurinia Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Aurinia Pharmaceuticals Inc's next earnings report?
Based on 5
analysts, Aurinia Pharmaceuticals Inc is expected to report EPS of $0.24 and revenue of $81.29M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement